Corify team continues growing!30 June, 2020
Corify Care participated in the CEI Satellite Meeting CinC 2020: Challenges in the Daily Application of ECGI13 November, 2020
Corify participates in the Itemas webinar series
Last 1st of July, Corify Care CEO and co-founder Andreu Climent participated in the 3rd webinar of the Covid-19 series organised by ITEMAS.
The webinar, “Fundraising experiences in ITEMAS projects” counted too on GlyCardial Diagnostics CEO and co-funder Judit Cubedo and AptaTargets CFO and co-founder María Eugenia Zarabozo. The three of them highlighted that having a solid scientific project and the right patent to protect it are key to raise funding in health innovation projects. Likewise, a deep knowledge of the market and a great team are also essential to attract investment.
According to Andreu, it is fundamental to prepare a good patent for your technology. The fact that their invention covers an unmet medical need has also been key to attract private investment. And also the fact that their technology solves a medical problem with a broad market, which will guarantee its profitability. Finally, he advises entrepreneurs to have clear milestones and to raise funding for each of them. “We are convinced -says Andreu- that in ten years we will succeed. We are just beginning our journey.”
The three entrepreneurs agree that Covid-19 pandemic has not affected them dramatically. On the contrary, Zarabozo believes that “the lockdown has been positive in the way that we have been able to meet some deadlines. The crisis has also prompted the opening of new financing instruments in the public sector”. Cubedo admits that Covid-19 “touched us at a critical moment and our clinical study had to be postponed. However we have seen an increasing interest by investors. Rounds are closed with higher amounts to guarantee the feasibility of projects”. Climent agrees: “once the worse of the crisis has passed, we have noticed that investors are even more interested.”
Beatriz Pérez, Innovation Manager at Hospital Gregorio Marañon’s Healthcare Research Institute and David Arbelo, Projects Director at Madrid Parque Científico’s Foundation moderated the discussion.